#HerHeart tool for Cardiovascular Diseases

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Grady Health System, Atlanta, GA
Cardiovascular Diseases
#HerHeart tool - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

The purpose of this study is to evaluate the web tool #HerHeart's usability and feasibility in adolescent and young adult women (AYA) and their healthcare providers (HCP).

Treatment Effectiveness

Study Objectives

10 Primary · 3 Secondary · Reporting Duration: Baseline, 3 month post intervention

Month 3
Change in BMI from baseline
Change in diastolic blood pressure (BP) from baseline
Change in systolic blood pressure (BP) from baseline
Baseline, 3 months post-intervention
Change in #HerHEART risk score in AYA from baseline
Change in fruit and vegetable intake
Change in overall composite of diet score
Change in red and processed meats intake
Changes in alcohol consumption
Changes in cereal fiber
Changes in nicotine use
Changes in nut consumption
Changes in physical activity
Changes in sugar and sweetened beverages

Trial Safety

Trial Design

2 Treatment Groups

HCP participants
1 of 2
AYA participants
1 of 2
Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: #HerHeart tool · No Placebo Group · N/A

HCP participants
Behavioral
Experimental Group · 1 Intervention: #HerHeart tool · Intervention Types: Behavioral
AYA participants
Behavioral
Experimental Group · 1 Intervention: #HerHeart tool · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 3 month post intervention
Closest Location: Grady Health System · Atlanta, GA
Photo of Atlanta 1Photo of Atlanta 2Photo of Atlanta 3
2011First Recorded Clinical Trial
4 TrialsResearching Cardiovascular Diseases
54 CompletedClinical Trials

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,494 Previous Clinical Trials
2,665,923 Total Patients Enrolled
21 Trials studying Cardiovascular Diseases
28,116 Patients Enrolled for Cardiovascular Diseases
Holly Gooding, MDPrincipal InvestigatorEmory University

Eligibility Criteria

Age Any Age · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are non-Hispanic Black or White.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.